Other languages Aptamer Group plc

Equities

Market Closed - London S.E. Other stock markets 16:35:05 17/05/2024 BST			5-day change	1st Jan Change
0.725 ^GBX	0.00%		+16.94%	-36.96%

05-13	Aptamer says sales pipeline "strong" as reports strategic headway	AN
04-22	EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings	AN

Aptamer says sales pipeline "strong" as reports strategic headway	05-13
EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings	04-22
Aptamer inks new Optimer+ transplant rejection therapy partnership	04-18
Aptamer Group Files Patent Application for Optimer Binders	04-08
Aptamer submits patent application for Optimer binders	04-08
EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles	03-28
Aptamer Group plc Reports Earnings Results for the Half Year Ended December 31, 2023	03-28
Zentek Says Potential COVID-19 Drug Shows 'Promising' Safety Profile in Preclinical Trial	03-25
Aptamer shares jump on successful Unilever contract progression	03-11
Aptamer Group, Unilever Prepare to Patent Optimers Developed Under Partnership	03-11
Aptamer says new Optimer+ delivers improved results	02-27
Aptamer Group plc Announces R&D Progress on New Optimer®? + Platform	02-27
Aptamer and Neuro-Bio begin Alzheimer's test development second phase	02-22
Aptamer Group, Neuro-Bio Enter Second Phase of Partnership for Alzheimer's Flow Test Development	02-22
Aptamer shares plunge as half-year revenue to fall by 70%	02-05
Aptamer Group plc Provides Revenue Guidance for the First Half of the Fiscal Year 2024	02-05
Ribomic Enters Into Drug Research Collaboration with Ajinomoto	01-17
Aptamer inks deal for Optimer discovery with biotech firm	12-14
Aptamer Group Signs Optimer Discovery Deal With Genetic Medicines Company	12-14
Aptamer Group plc Announces Material Agreement with Genetic Medicines Company	12-14

No results for this search